Major Progress of Malignant Lymphoma in 2019-Follow Evidence-based Medicine, and Continue to Promote the Standardization of Diagnosis and Treatment of Lymphoma

LIN Ning-jing; ZHU Jun

doi:10.12019/j.issn.1671-5144.2020.02.001

LIN Ning-jing, ZHU Jun. Major Progress of Malignant Lymphoma in 2019-Follow Evidence-based Medicine, and Continue to Promote the Standardization of Diagnosis and Treatment of Lymphoma[J]. Journal of Evidence-Based Medicine, 2020, 20(2): 65-71. DOI: 10.12019/j.issn.1671-5144.2020.02.001

Citation:

LIN Ning-jing, ZHU Jun. Major Progress of Malignant Lymphoma in 2019-Follow Evidence-based Medicine, and Continue to Promote the Standardization of Diagnosis and Treatment of Lymphoma[J]. Journal of Evidence-Based Medicine, 2020, 20(2): 65-71. DOI: 10.12019/j.issn.1671-5144.2020.02.001

Citation:

LIN Ning-jing, ZHU Jun. Major Progress of Malignant Lymphoma in 2019-Follow Evidence-based Medicine, and Continue to Promote the Standardization of Diagnosis and Treatment of Lymphoma[J]. Journal of Evidence-Based Medicine, 2020, 20(2): 65-71. DOI: 10.12019/j.issn.1671-5144.2020.02.001

Major Progress of Malignant Lymphoma in 2019-Follow Evidence-based Medicine, and Continue to Promote the Standardization of Diagnosis and Treatment of Lymphoma

Graphical Abstract

Abstract

FullText(HTML)

References (58)

Major Progress of Malignant Lymphoma in 2019-Follow Evidence-based Medicine, and Continue to Promote the Standardization of Diagnosis and Treatment of Lymphoma

Catalog

Export File

Citation

Format

Content